Xcout Intel
Neurable Inc.
Neurable Inc. is a Boston-based neurotechnology company specializing in AI-powered tools for brain signal translation, including integrated neurotechnology gaming headsets.
Subscribe to see Neurable Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Neurable Inc. at a glance
Neurable Inc. is a neurotechnology company headquartered in United States. Its most recent funding round, Series A, raised $35M in December 2025. Xcout tracks 3 named people at Neurable Inc., including Eugene Goldberg (VP of Business Development).
Neurable Inc. leadership
- Eugene GoldbergVP of Business Development
- Lindsay NieVice President of Engineering
- Annika HelendiHead of Marketing / GTM Lead
Neurable Inc. funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $35M | 5 named | |
| — | $13M | 4 named | |
| SEC Form D filing | $5.7M | — | |
| SEC Form D filing | $1M | — | |
| SEC Form D filing | $4.9M | — | |
| Seed | $2M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Neurable Inc. competitors
A few of Neurable Inc.'s closest competitors — see the full list of competitors and alternatives →
Cephable is a remote-first, U.S.-based human-first productivity platform headquartered in Boston that provides personalized accessibility controls across software.
Neuble AI Co., Ltd. is a South Korean startup based in Seoul that develops artificial intelligence-based diagnostic and analysis software solutions for brain diseases.
QuEra Computing Inc. is a quantum computing company headquartered in Boston, Massachusetts, that builds commercial quantum computers utilizing neutral atoms based on pioneering academic research.
Anthriq, formerly known as Nexstem, is a Bengaluru-based deep-tech startup specializing in biosignal hardware and AI-native neural technology. The company develops EEG and software solutions for global commercialization without the need for brain implants.
INBRAIN Neuroelectronics develops graphene-based brain-computer interface (BCI) platforms and AI-driven neurotherapeutics designed to decode and modulate neural signals. The company serves patients with brain disorders and neurological conditions, such as Parkinson's disease, by providing real-time, personalized autonomous therapy.
Get Neurable Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Neurable Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access